OptiLight 2.0 ‘easier, faster to use’ to treat dry eye disease
Click Here to Manage Email Alerts
NEW YORK — Lumenis, makers of the OptiLight intense pulsed light treatment for dry eye, released the next generation of the device to decrease treatment time and improve workflow, according to a company executive at Vision Expo East.
Itay Mayer, Lumenis Vision vice president and managing director, told Healio that OptiLight 2.0 was introduced in February, nearly 2 years after the FDA approved OptiLight as the first intense pulsed light (IPL) treatment for dry eye.
“Doctors were seeing a lot of patients, but there was a need to improve the workflow,” Mayer said. “We redesigned the software to make it easier and faster to use.”
OptiLight 2.0 remembers patients, so parameters are already set, he said. Treatment time is reduced, and the system connects directly to the electronic health record. A remote capability for service and support was also added, as well as a voice-to-text feature.
Lumenis will send technicians to practices who already own the OptiLight technology to upgrade the software, he said. The company is also working with state optometric associations and schools as scopes of practice expand, offering training.
This year, the company is increasing its investment to improve awareness of dry eye with direct-to-consumer marketing, including ads for Lumenis’ new dry eye campaign, “Not Gonna Live With It,” featuring celebrity Mandy Moore.
Mayer said the company has also partnered with Marketing4ECPs to support doctors with education, including information on patient selection and how to integrate the technology into the office/patient flow.
Collapse
Healio Interviews
Read more about
Click Here to Manage Email Alerts